WATANABE TODD sold 0.4% of their position (3.17K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $74.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/6/2026ACC: 0001801061-26-000003
Director
Since Jan 2020
-3.17K
Net shares
Net seller
$74.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.17K
Price / share
$23.61
Trade value
$74.89K
% of position
0.4%
5/4/2026
723.93K→720.75K
Total
Net shares
−3.17K
Net value
-$74.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | S · Sale | −3.17K | $23.61 | $74.89K | 0.4% | 723.93K | 720.75K |
| Total | −3.17K | -$74.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned25.41K
Common Stock
IndirectShares owned25.41K
Common Stock
IndirectShares owned57.36K
Common Stock
IndirectShares owned124.96K
Total
233.13K indirect233.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.41K | Indirect |
| Common Stock | 25.41K | Indirect |
| Common Stock | 57.36K | Indirect |
| Common Stock | 124.96K | Indirect |
| Total | 233.13K | 233.13K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported